Curaleaf Holdings Reports Q1 2025 Results with Strong International Growth

Curaleaf Holdings ( (TSE:CURA) ) has issued an update.

Curaleaf Holdings reported a total revenue of $310 million for the first quarter of 2025, with a notable international revenue growth of 74% year-over-year. Despite a decrease in net revenue compared to the previous year, the company achieved a 50% adjusted gross margin and continued to expand its product offerings and retail locations, demonstrating resilience and strategic positioning for long-term success.

Spark’s Take on TSE:CURA Stock

According to Spark, TipRanks’ AI Analyst, TSE:CURA is a Neutral.

Curaleaf Holdings’ overall stock score reflects a blend of moderate financial performance, neutral technical indicators, and challenging valuation metrics. The company’s stable revenue and international growth are positive aspects, but the persistent net losses, increasing leverage, and lack of dividend yield weigh down the score. The earnings call suggests optimism for future growth, yet significant challenges remain in domestic markets and debt management.

To see Spark’s full report on TSE:CURA stock, click here.

More about Curaleaf Holdings

Curaleaf Holdings, Inc. is a leading international provider of consumer products in the cannabis industry. The company focuses on offering a range of cannabis products, including innovative items such as hemp THC energy drinks and pre-rolls, with a strong market presence in the United States and international markets.

Average Trading Volume: 425,547

Technical Sentiment Signal: Sell

Current Market Cap: C$905.6M

See more data about CURA stock on TipRanks’ Stock Analysis page.